Korea Health Industry Development Institute Supports 12 Korean Companies Based in Houston ... Expands Cooperation With U.S. Hospitals and Investors
- Input
- 2026-11-16 10:48:57
- Updated
- 2026-11-16 10:48:57

The Korea Health Industry Development Institute said on the 16th that it had visited Houston, United States, from the 9th to the 14th to review the activities of 12 Korean medical device and pharmaceutical-biotechnology companies based at the Texas Medical Center (TMC) and discuss ways to cooperate.
The institute signed a memorandum of understanding with TMC last June and has supported 12 Korean companies in moving into TMC Innovation Factory since July. The visit was arranged to review the four months of activity since the companies moved in and help them build practical partnerships with the U.S. healthcare and industry ecosystem.
The resident companies also sought opportunities for investment and clinical collaboration. They took part in the Texas Life Science Forum (TLSF) and TMC Envision 2026, held on the 10th and 11th, and met with investors and clinical research professionals.
In particular, Celebrain was selected as a presenting company at TLSF and introduced its technology and commercialization potential to investors. It then explored the possibility of follow-on investment through one-on-one consultations. At TMC Envision 2026, the companies examined clinical research environments at medical institutions and ways to streamline early-stage clinical trials.
On the 12th, five Houston-based resident companies and one Boston-based company supported by the institute took part in TMC's one-on-one expert advisory program. The companies held individual consultations with 12 experts in regulatory approval, clinical matters, insurance reimbursement, commercialization and investment.
The institute also pursued cooperation with Korean American expert networks. It met with representatives in Texas of the Korean-American Scientists and Engineers Association (KSEA) and the Korean American Society in Biotech and Pharmaceuticals (KASBP) to discuss ways to connect Korean companies with experts as they expand into the U.S. market.
The annual banquet of the Korean American Medical Association Texas Chapter (KAMA Texas) also provided an opportunity to broaden connections with medical professionals. About 150 people attended the event, sponsored by the institute, including Korean American medical professionals from the Houston area. Before the event, the resident companies set up tables to introduce their technologies and products, and promoted their products through one-minute presentations during the main program.
Jung Young-hoon, planning director at the institute, said, "We will support companies' entry into the U.S. market through our network of cooperation with medical professionals and Korean American experts, and work to turn that into results, including the adoption of their products by hospitals."
[email protected] Jung Sang-hee Reporter